Robin Warren Selected Research

Robin Warren Research Topics

13	Tuberculosis (Tuberculoses) 01/2022 - 03/2002
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2022 - 09/2002
3	Extensively Drug-Resistant Tuberculosis 01/2018 - 01/2013
2	Infections 11/2019 - 01/2017
2	Coinfection 01/2017 - 09/2002
1	Anemia 01/2022
1	Hearing Loss (Hearing Impairment) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Cough 01/2020
1	Pulmonary Tuberculosis 01/2017
1	Renal Insufficiency (Renal Failure) 01/2013
1	Hypokalemia 01/2013
1	HIV Infections (HIV Infection) 05/2010

9	Pharmaceutical PreparationsIBA 01/2020 - 04/2002
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 01/2017
2	Capreomycin (Capastat)FDA Link 01/2015 - 01/2013
1	bedaquiline (R207910)IBA 01/2022
1	Linezolid (Zyvox)FDA Link 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Kanamycin FDA Link 01/2022
1	FluoroquinolonesIBA 01/2022
1	AerosolsIBA 01/2020
1	MitogensIBA 11/2019
1	Interferon-gamma (Interferon, gamma)IBA 11/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Tuberculin (PPD)IBA 01/2018
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2017
1	LigandsIBA 12/2013
1	PolymersIBA 12/2013
1	Moxifloxacin (Avelox)FDA Link 05/2010
1	AcidsIBA 03/2002

2	Duration of Therapy 01/2022 - 01/2020
2	Therapeutics 01/2017 - 01/2013
1	Injections 01/2022
1	Drug Substitution 01/2022
1	Immunotherapy 01/2018
1	Palliative Care (Palliative Therapy) 04/2014
1	Highly Active Antiretroviral Therapy (HAART) 05/2010